Calithera Biosciences (NASDAQ:CALA) Coverage Initiated by Analysts at StockNews.com

StockNews.com started coverage on shares of Calithera Biosciences (NASDAQ:CALA) in a research note issued on Wednesday. The brokerage set a “hold” rating on the biotechnology company’s stock.

Calithera Biosciences Price Performance

Calithera Biosciences has a fifty-two week low of $0.00 and a fifty-two week high of $0.12.

Calithera Biosciences Company Profile

Calithera Biosciences, Inc operates under a plan of liquidation that was approved in January 2023. Previously, the company was engaged in the clinical stage precision oncology biopharmaceutical business. Calithera Biosciences, Inc was incorporated in 2010 and is headquartered in South San Francisco, California.